The trademark SUDRALEX was filed by MACURE PHARMA ApS, a corporation established under the laws of the Kingdom of Denmark (the "Applicant"). The application was published for oppositions on January 29, 2023, and received one opposition filed on April 27, 2023 by BIOFARMA on (a) Identity of marks and Goods and Services, (b) Likelihood of confusion. the opponent was represented by CABINET GERMAIN & MAUREAU and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued April 27, 2023
The application was filed in Danish, and Danish was also language of all opposition proceedings (English was selected as the second language).